Anavex Life Sciences Corp (AVXL)

[McMagyar]

well said. We invest in an area that has had a 99% fail rate and worry about terms of addittional funding? We have additional funding! Even more excitedly with the data from Phase 2a Part A and Part B( originally scheduled for 26 Weeks) we know that A2-73 has the possiblitiy to effect Insomnia( $32 Billion Annual US Market), Depression ($? Billion) et al..
these are NOT IND's with 99% Fail Rates!
Our Company has gone from a one and done IND to a Broad ranged Pharmaceutical Co. with possible effective treatment for multiple CNS diseases AND ..let me remind everyone again..
IF A2-73 is effectively engaging the S1 Ligand in the CNS area , chances are A2-73 is also effecting the S1 Ligand in MANY < MANY Other areas of Human Function! Thus creating a Super Drug!

Nowhere are any of these developments reflected in the Value of Anavex!

We are undervalued by..it doesn't matter by how much..
But undervalued stocks after positive developments/announcements
also become overvalued stocks..
keep that in mind!